1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine

C136H219F3N22O8 — CID 160519221

IUPAC1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine
SMILESCC(=O)N(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CC(=O)N1CC(Cc2cc(C(C)(C)C)cnn2)C1.CC(=O)N1CCC(Cc2cc(C(C)(C)C)cc(OCCN(C)C)n2)CC1.CC(C)(C)c1cnnc(OC2CCN(CC(F)(F)F)CC2)c1.CCN(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CNC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COc1cc(C(C)(C)C)cc(CC2CCN(C(C)=O)CC2)n1
InChIInChI=1S/C21H35N3O2.C18H29N3O.C18H31N3.C18H28N2O2.C16H27N3.C16H26N2O.C15H22F3N3O.C14H21N3O/c1-16(25)24-9-7-17(8-10-24)13-19-14-18(21(2,3)4)15-20(22-19)26-12-11-23(5)6;1-13(22)21(5)16-8-6-14(7-9-16)10-15-11-17(18(2,3)4)20-12-19-15;1-6-21(5)16-9-7-14(8-10-16)11-15-12-17(18(2,3)4)20-13-19-15;1-13(21)20-8-6-14(7-9-20)10-16-11-15(18(2,3)4)12-17(19-16)22-5;1-16(2,3)15-10-14(18-11-19-15)9-12-5-7-13(17-4)8-6-12;1-16(2,3)15-10-13(17-11-18-15)9-12-5-7-14(19-4)8-6-12;1-14(2,3)11-8-13(20-19-9-11)22-12-4-6-21(7-5-12)10-15(16,17)18;1-10(18)17-8-11(9-17)5-13-6-12(7-15-16-13)14(2,3)4/h14-15,17H,7-13H2,1-6H3;11-12,14,16H,6-10H2,1-5H3;12-14,16H,6-11H2,1-5H3;11-12,14H,6-10H2,1-5H3;10-13,17H,5-9H2,1-4H3;10-12,14H,5-9H2,1-4H3;8-9,12H,4-7,10H2,1-3H3;6-7,11H,5,8-9H2,1-4H3
InChIKeyQUBBDCXMGLEBRJ-UHFFFAOYSA-N
MW2347.39 g/mol
LogP25.08
Rot. Bonds27

About 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine

1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine (PubChem CID 160519221) has the molecular formula C136H219F3N22O8 and a molecular weight of 2347.39 g/mol. Its IUPAC name is 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine.

Molecular Properties

Compound Name1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine
PubChem CID160519221
Molecular FormulaC136H219F3N22O8
Molecular Weight2347.39 g/mol
Exact Mass2345.74
IUPAC Name1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine
SMILESCC(=O)N(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CC(=O)N1CC(Cc2cc(C(C)(C)C)cnn2)C1.CC(=O)N1CCC(Cc2cc(C(C)(C)C)cc(OCCN(C)C)n2)CC1.CC(C)(C)c1cnnc(OC2CCN(CC(F)(F)F)CC2)c1.CCN(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CNC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COc1cc(C(C)(C)C)cc(CC2CCN(C(C)=O)CC2)n1
InChIInChI=1S/C21H35N3O2.C18H29N3O.C18H31N3.C18H28N2O2.C16H27N3.C16H26N2O.C15H22F3N3O.C14H21N3O/c1-16(25)24-9-7-17(8-10-24)13-19-14-18(21(2,3)4)15-20(22-19)26-12-11-23(5)6;1-13(22)21(5)16-8-6-14(7-9-16)10-15-11-17(18(2,3)4)20-12-19-15;1-6-21(5)16-9-7-14(8-10-16)11-15-12-17(18(2,3)4)20-13-19-15;1-13(21)20-8-6-14(7-9-20)10-16-11-15(18(2,3)4)12-17(19-16)22-5;1-16(2,3)15-10-14(18-11-19-15)9-12-5-7-13(17-4)8-6-12;1-16(2,3)15-10-13(17-11-18-15)9-12-5-7-14(19-4)8-6-12;1-14(2,3)11-8-13(20-19-9-11)22-12-4-6-21(7-5-12)10-15(16,17)18;1-10(18)17-8-11(9-17)5-13-6-12(7-15-16-13)14(2,3)4/h14-15,17H,7-13H2,1-6H3;11-12,14,16H,6-10H2,1-5H3;12-14,16H,6-11H2,1-5H3;11-12,14H,6-10H2,1-5H3;10-13,17H,5-9H2,1-4H3;10-12,14H,5-9H2,1-4H3;8-9,12H,4-7,10H2,1-3H3;6-7,11H,5,8-9H2,1-4H3
InChIKeyQUBBDCXMGLEBRJ-UHFFFAOYSA-N
XLogP25.08
TPSA320.37 Ų
H-Bond Donors1
H-Bond Acceptors26
Rotatable Bonds27
Heavy Atoms169
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002347.39
LogP ≤ 525.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1026

Analyze 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine?
The IUPAC name of 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine (CID 160519221) is 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine.
What is the SMILES notation for 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine?
The canonical SMILES for 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine is CC(=O)N(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CC(=O)N1CC(Cc2cc(C(C)(C)C)cnn2)C1.CC(=O)N1CCC(Cc2cc(C(C)(C)C)cc(OCCN(C)C)n2)CC1.CC(C)(C)c1cnnc(OC2CCN(CC(F)(F)F)CC2)c1.CCN(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CNC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COc1cc(C(C)(C)C)cc(CC2CCN(C(C)=O)CC2)n1.
What is the InChIKey of 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine?
The InChIKey is QUBBDCXMGLEBRJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H35N3O2.C18H29N3O.C18H31N3.C18H28N2O2.C16H27N3.C16H26N2O.C15H22F3N3O.C14H21N3O/c1-16(25)24-9-7-17(8-10-24)13-19-14-18(21(2,3)4)15-20(22-19)26-12-11-23(5)6;1-13(22)21(5)16-8-6-14(7-9-16)10-15-11-17(18(2,3)4)20-12-19-15;1-6-21(5)16-9-7-14(8-10-16)11-15-12-17(18(2,3)4)20-13-19-15;1-13(21)20-8-6-14(7-9-20)10-16-11-15(18(2,3)4)12-17(19-16)22-5;1-16(2,3)15-10-14(18-11-19-15)9-12-5-7-13(17-4)8-6-12;1-16(2,3)15-10-13(17-11-18-15)9-12-5-7-14(19-4)8-6-12;1-14(2,3)11-8-13(20-19-9-11)22-12-4-6-21(7-5-12)10-15(16,17)18;1-10(18)17-8-11(9-17)5-13-6-12(7-15-16-13)14(2,3)4/h14-15,17H,7-13H2,1-6H3;11-12,14,16H,6-10H2,1-5H3;12-14,16H,6-11H2,1-5H3;11-12,14H,6-10H2,1-5H3;10-13,17H,5-9H2,1-4H3;10-12,14H,5-9H2,1-4H3;8-9,12H,4-7,10H2,1-3H3;6-7,11H,5,8-9H2,1-4H3.
What are the key properties of 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine?
1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine has a molecular weight of 2347.39 g/mol, XLogP of 25.08, 27 rotatable bonds, 1 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine is sourced from PubChem (CID 160519221), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).